12th December 2019, Kohinoor Continental Hotel, Mumbai, India
14th Biosimilars Congregation 2019 will be your opportunity with leading industry experts to discuss from development, manufacturing to commercialization - The current landscape, legal, regulatory, funding, challenges, market access strategy, business models and how to get to market.
NAVITAS LIFE SCIENCES
We also have more sponsorship opportunities available for the event, which gives you an opportunity to sponsor/speak/exhibit, and create brand awareness. In addition, the networking opportunities in focused and relevant industry gathering provide the personal contact necessary for business development efforts.
ASHOK KUMAR, President Centre for Research & Development, Ipca Laboratories
MAYUR PARMAR, Deputy Collector, Government Of Gujarat
HANMANT BARKATE, Vice President & Head Medical Services (India & MEA), Glenmark Pharmaceuticals
ARUN BHATT, Consultant Clinical Research & Development
SAMIR KULKARNI, Consultant Biosimilars Product development
MANISH MAHAJAN, Head- Medical Affairs, Cadila Healthcare (BU- Biologics)
DEVESH BHARDWAJ, Head Biotechnology R&D, Mankind Pharma
ALAP GANDHI, Head- Medical Affairs, GSK
SRIVANI MUKKAMALA, Independent Consultant
GAURAV AGARWAL, Biosimilars Program Manager, Wockhardt
PRADEEP NAGALKAR, Head of Quality Control, Haffkine Biopharmaceutical
HARSHAD RASANE, Clinical Operations Biosimilars, Reliance Life Sciences
PRANJAL BORDOLOI, Vice President Clinical Medical Affairs & Pharmacovigilance, Veeda Clinical Research
THOMAS PHILIP, Senior Manager Digital Strategy and Analytics, Cipla
ROSHAN PAWAR, Senior Medical Advisor, Oncology, Alkem Laboratories
HEMANT ZAVERI, General Manager - Head Medical Affairs, Otsuka Pharmaceuticals
PRASHANT BODHE, Director, CliniSearch
Plus many more
KEY THEMES DISCUSSED:
Biosimilar companies ' market assessment Where are we to ahead?
Present state and future scenario of the biosimilar market.
Why does India need biotechnology to guarantee the safety of food, feed and nutrition?
What are Indian institutes and scientists ' innovative biotechnological methods?
Current landscape and policy updates for global biosimilars
Discussing pricing approach and value management as a growing need
Current challenges in developing biosimilars
Scientific and strategic approaches taken for successfully developing of follow-on-biologics
How and when should investors be involved in biotech funding?
Product processing and production, permits and licensing and other direct costs
Biosimilars & Biobetters development
Product development, marketing authorisation and post-registration surveillance differences between generics and biosimilars
Discussing about the growth statistics of biopharmaceutical industry in India
Challenges faced in the development and production of biosimilars
Regulatory authorities guidelines for the advancement and approval of biosimilars
Strategies for better regulatory expertise and cross-nation support for advance regulatory policy innovation
Be part of a major networking opportunity
WHO SHOULD ATTEND:
CSOs, CMOs, Vice Presidents, Presidents, Heads, Directors, Team Leaders, and Senior Scientists from the following roles:
Biopharmaceuticals/ Biotherapeutics, Follow on Biologics/Follow on Proteins, Biologics/Biotechnology/ Bio generics, Legal Affairs, Intellectual Property, Health Economics, Pricing and Reimbursement, Clinical Immunology, Principal Scientist, Chief Scientific Officer, Process Control and Analytical Technologies, Analytical Characterisation, Regulatory Compliance, Pharmacovigilance, Drug Safety & Risk Management, Quality Affairs/ Quality Control, New Product Development, Process Science, Portfolio Management, Research & Development, Business Development, Business Operations, Scientific Affairs, Commercial Affair
Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.
EventsHigh Specials, intellectual property, regulatory compliance, mukkamala, biotechnology, statistics, ashok kumar, research development, characterisation, clinical research, technology, arts and culture, classes and workshops, fun and games,